Neuromuscular dysfunction and pathogenesis in triosephosphate isomerase deficiency.
Tracey D Myers1,2,3, Yizhi Li1,4, Stefanie Taiclet2,5
1Center for Neuroscience at the University of Pittsburgh, Pittsburgh, PA, USA.
Scientific Reports
|August 10, 2024
Summary
Triosephosphate isomerase deficiency (TPI Df) causes severe neuromuscular issues due to TPI1 gene mutations. A new mouse model reveals neurodegeneration and muscle fiber loss contributing to TPI Df symptoms.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Triosephosphate isomerase deficiency (TPI Df) is a rare genetic disorder.
- Severe neuromuscular symptoms characterize TPI Df, stemming from TPI1 gene mutations.
- Limited research exists due to a lack of suitable animal models and patient samples.
Purpose of the Study:
- To elucidate the pathogenesis of neuromuscular symptoms in TPI Df.
- To characterize neuromuscular and cardiac pathology in a novel murine model of TPI Df.
- To investigate the effects of the TPI1E105D mutation in a mammalian system.
Main Methods:
- Development of a novel murine model mimicking the common human TPI1E105D mutation.
- Histopathological analysis of neuromuscular tissues (brain, neuromuscular junctions, muscle fibers).
- Assessment of cardiac function and vascular smooth muscle activity in TPI Df mice.
Main Results:
- Neurodegeneration observed in the brain of TPI Df mice.
- Alterations in neurotransmission at the neuromuscular junction were identified.
- Reduced muscle fiber size and cardiac pathology were evident.
- Deficits in vascular smooth muscle functionality were noted.
Conclusions:
- This study provides the first detailed report on neuromuscular pathology in a murine TPI Df model.
- Identified neurodegeneration, altered neurotransmission, and muscle atrophy as key contributors to TPI Df symptoms.
- Findings offer insights into TPI Df pathogenesis and potential therapeutic targets.
Related Concept Videos
Inborn Errors of Metabolism
148
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
148
Disorders of the Skeletal Muscle
917
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
917
ATP Synthase: Mechanism
14.3K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.3K
The Electron Transport Chain
16.4K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
16.4K
Myasthenia Gravis: Diagnostic Tests
723
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
723
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K


